Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Endocrinology

Pharmacology/kinetics

Differences in health outcomes associated with initial adherence to oral antidiabetes medications among veterans with uncomplicated Type 2 diabetes: A 5-year survival analysis

Diabetic Medicine | Jul 16, 2018 Pharmacology/kinetics

Impact of treatment with glibenclamide or vildagliptin on glucose variability after aerobic exercise in type 2 diabetes: A randomized controlled trial

Diabetes Research and Clinical Practice | Jul 16, 2018 Pharmacology/kinetics

Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD

Journal of Clinical Endocrinology & Metabolism | Jul 15, 2018 Pharmacology/kinetics

A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The Merit study

Diabetes, Obesity and Metabolism | Jul 13, 2018 Pharmacology/kinetics

Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin vs glimepiride as add-on to metformin in patients with type 2 diabetes

Diabetes, Obesity and Metabolism | Jul 12, 2018 Pharmacology/kinetics

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: Subanalysis of the EMPA-REG OUTCOME randomised trial

Diabetologia - Clinical and Experimental Diabetes and Metabolism | Jul 11, 2018 Pharmacology/kinetics

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: A double-blind randomised placebo-controlled study

Diabetologia - Clinical and Experimental Diabetes and Metabolism | Jul 10, 2018 Pharmacology/kinetics

Sotagliflozin in combination with optimized insulin therapy in adults with type 1 diabetes: The North American inTandem1 Study

Diabetes Care | Jul 04, 2018 Pharmacology/kinetics

HbA_1c and hypoglycemia reductions at 24 and 52 weeks with sotagliflozin in combination with insulin in adults with type 1 diabetes: The European inTandem2 Study

Diabetes Care | Jul 02, 2018 Pharmacology/kinetics

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study

Diabetes, Obesity and Metabolism | Jul 01, 2018 Pharmacology/kinetics

« Prev 1 … 92 93 94 95 96 … 122 Next »

Differences in health outcomes associated with initial adherence to oral antidiabetes medications among veterans with uncomplicated Type 2 diabetes: A 5-year survival analysis

Impact of treatment with glibenclamide or vildagliptin on glucose variability after aerobic exercise in type 2 diabetes: A randomized controlled trial

Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD

A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The Merit study

Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin vs glimepiride as add-on to metformin in patients with type 2 diabetes

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: Subanalysis of the EMPA-REG OUTCOME randomised trial

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: A double-blind randomised placebo-controlled study

Sotagliflozin in combination with optimized insulin therapy in adults with type 1 diabetes: The North American inTandem1 Study

HbA_1c and hypoglycemia reductions at 24 and 52 weeks with sotagliflozin in combination with insulin in adults with type 1 diabetes: The European inTandem2 Study

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Minimally Invasive Dentistry

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

More Women Experience Chronic Pain Than Men: Find Out Why

Differences in health outcomes associated with initial adherence to oral antidiabetes medications among veterans with uncomplicated Type 2 diabetes: A 5-year survival analysis

Impact of treatment with glibenclamide or vildagliptin on glucose variability after aerobic exercise in type 2 diabetes: A randomized controlled trial

Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD

A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The Merit study

Efficacy and safety of dapagliflozin or dapagliflozin plus saxagliptin vs glimepiride as add-on to metformin in patients with type 2 diabetes

Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: Subanalysis of the EMPA-REG OUTCOME randomised trial

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: A double-blind randomised placebo-controlled study

Sotagliflozin in combination with optimized insulin therapy in adults with type 1 diabetes: The North American inTandem1 Study

HbA1c and hypoglycemia reductions at 24 and 52 weeks with sotagliflozin in combination with insulin in adults with type 1 diabetes: The European inTandem2 Study

Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): The DERIVE Study

Pelvic Floor Disorders: Causes, Diagnosis & Treatment

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Minimally Invasive Dentistry

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

More Women Experience Chronic Pain Than Men: Find Out Why

Select Specialty

Select Topic

HbA_1c and hypoglycemia reductions at 24 and 52 weeks with sotagliflozin in combination with insulin in adults with type 1 diabetes: The European inTandem2 Study